{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7R9dcIDA","lastupdate":"2022-12-01T00:00:00.000Z","update_date":"2022-12-01T00:00:00.000Z","lastModified":"Nov 18, 2024","active":1,"confidence_score":92,"confidence_score_reason":"markets, not claimed","urlname":"biosense-webster","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Johnson & Johnson on Sep, 1997","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$eqVfeKBye9VzuBBd6GSDnEvVKaHzrvjKjKYtX8XdYGeYlWaGSXY1O8","name":"Biosense Webster","oneliner":"Diagnosis and Treatment of Cardiac Arrhythmias","registrar":"511859134","website":"http://www.biosensewebster.com","careerspage":"","founded_month":9,"founded_year":1993,"formernames":["Biosense"],"sociallinks":{"twitter":"https://twitter.com/biosensewebster","youtube":"https://www.youtube.com/channel/UCoj1mFvOB29eZjNZnTlB7jA","facebook":"https://www.facebook.com/biosensewebsterjnj","linkedin":"https://www.linkedin.com/company/1194","instagram":""},"social":["https://www.linkedin.com/company/1194","https://www.facebook.com/biosensewebsterjnj","https://twitter.com/biosensewebster","https://www.youtube.com/channel/UCoj1mFvOB29eZjNZnTlB7jA"],"flattenedsociallinks":"https://www.linkedin.com/company/1194|https://www.facebook.com/biosensewebsterjnj|https://twitter.com/biosensewebster|https://www.youtube.com/channel/UCoj1mFvOB29eZjNZnTlB7jA","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"500+","employees_exact":3023,"patent":1,"raised":0,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Biosense Webster develops solutions designed to diagnose and treat cardiac arrhythmias. The company enables physicians to find and treat more types of disease by contributing directly to improving procedural methodologies and raising success rates.\r\n\r\nBiosense Websters CARTO Solutions provide navigational and mapping features to help physicians better treat theirpatients. Advanced 3D mapping modules integrate multiple datasets and images into one resource for highly detailed, real-time information.\r\n\r\nThe company is a division of Johnson & Johnson Medical NV/SA.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97248131111","country":null,"address":{"israeli":[{"id":"2334155d-15c2-479a-a6bf-5c5d35b24585","city":"Yokne'am Illit","type":null,"address":"HaTnufa St 4, Yokne'am Illit, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"2cb8c044-97ca-49eb-a3b7-2d4c98b74c3d","city":"Madrid","address":"Paseo Doce Estrellas, 5-7, Madrid, Spain","country":"Spain","placeid":null},{"id":"3c842ab2-edf0-4df1-a459-314ab086d992","city":null,"address":"Staffans vg, Sollentuna, Sweden","country":"Sweden","placeid":null},{"id":"42839466-f65c-47f6-9365-58ef1fc61fdc","city":null,"address":"Via del Mare, 56, Pomezia, Metropolitan City of Rome, Italy","country":"Italy","placeid":null},{"id":"42881ea1-7182-4089-b916-e7b617807e9f","city":"Norderstedt","address":"Robert-Koch-Strae 1, Norderstedt, Germany","country":"Germany","placeid":null},{"id":"650c5a64-768a-475d-aaab-d63511d85582","city":"Irvine","address":"33 Technology Drive, Irvine, CA 92618, USA","country":"United States","placeid":null},{"id":"709a79b2-230d-4f33-b5d3-84cde3ad640e","city":"Midrand","address":"2 Medical Road, Randjespark, Midrand, Johannesburg, South Africa","country":"South Africa","placeid":null},{"id":"73ab7314-2f6f-4394-8c21-7f582a73dbfd","city":"Dublin","address":"Airton Road, Tallaght, Dublin, Ireland","country":"Ireland","placeid":null},{"id":"891b5589-9e56-4806-8cf1-3dcda395b07a","city":"Zug","address":"Gubelstrasse 34, Zug, Switzerland","country":"Switzerland","placeid":null},{"id":"b4952e42-847d-4a9d-a7bb-5666308049c2","city":"Machelen","address":"Leonardo da Vincilaan 15, Diegem 1831 Machelen, Belgium","country":"Belgium","placeid":null},{"id":"f3cee447-d3db-4942-9db4-821cfa54f58e","city":null,"address":"Estrada Consiglieri Pedroso 69, Portugal","country":"Portugal","placeid":null},{"id":"f40f4df5-6863-466e-91d8-0e1d7a6c8d7c","city":"Issy-les-Moulineaux","address":"Rue Camille Desmoulins, Issy-les-Moulineaux, France","country":"France","placeid":null},{"id":"f548722e-a8bf-4d73-b5cf-0ee869f3c3ff","city":"Finchampstead","address":"Nine Mile Ride, Finchampstead, Wokingham, UK","country":"United Kingdom","placeid":null}]},"headquarter_address":null,"district":"North District","news":[{"id":"kaxS3w7LEBxC53gQJ0F2BRABX6S9dHm9QyHoJl98uMIZZHfIjAo04G","date":"Oct 17, 2022","link":"https://www.news-medical.net/news/20221017/Biosense-Webster-launches-HELIOSTARe284a2-in-Europe-the-first-radiofrequency-Balloon-Ablation-Catheter-enabling-physicians-to-perform-more-efficient-cardiac-ablations.aspx","source":"www.news-medical.net","visible":1,"analysis":{"tags":"Medical Science News, Medical Research News, Miscellaneous News, Healthcare News","company":"Biosense Webster, Inc.","layoffs":null,"summary":"Biosense Webster, Inc., a part of Johnson & Johnson MedTech, has launched the HELIOSTAR Balloon Ablation Catheter in Europe. The catheter is the first radiofrequency balloon ablation catheter and is indicated for use in catheter-based cardiac electrophysiological mapping and ablation. The HELIOSTAR catheter is fully integrated with the CARTO 3 System, a 3D mapping solution, and offers a compliant balloon that can conform to varied pulmonary vein anatomy. It provides the ability to achieve single-shot pulmonary vein isolation in 12 seconds. The launch of the HELIOSTAR catheter is expected to have a positive impact on the growth of Biosense Webster, as it offers an effective and efficient technology for cardiac ablations. The article discusses the benefits of the catheter, including shorter procedure times, reduced fluoroscopy time and exposure, and potential improvements in patient access.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["HELIOSTAR Balloon Ablation Catheter","cardiac ablations","atrial fibrillation","catheter ablation","European launch"],"date_of_event":"October 17, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"RbbAw9cSanwjtCZFFrpSoiZXiQldKN0Ik4lVZsRcy3skk20R3zLgmO","news_summary":"Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"LdmED9rMO9JUdFSYHt70NV5gdhdTbz2u3eZP1SyR1TuwPKrWQbt9Re","date":"Sep 6, 2022","link":"https://www.jnj.com/biosense-webster-launches-the-octaray-mapping-catheter-with-trueref-technology","source":"www.jnj.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"3c1Vec9VsFL4STXOG75vTDnh2RBi3BLs1B90ku0wFJB4LRh9omtqUE","news_summary":"Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"3b8267f8-4b77-40ac-b687-dbd68da23f07","date":"Jul 1, 2019","link":"https://www.medicaldesignandoutsourcing.com/innovative-health-lands-another-catheter-reprocessing-clearance/","source":"www.medicaldesignandoutsourcing.com","visible":1,"analysis":{"tags":"FDA clearance, medical device reprocessing","company":"Innovative Health","layoffs":"NA","summary":"Innovative Health has received FDA clearance to reprocess the Biosense Webster PentaRay Nav eco high-density mapping catheter for reuse. The clearance allows the company to reprocess catheters, potentially saving hospitals thousands of dollars on each atrial fibrillation (AF) procedure. The PentaRay cardiology mapping catheter can do high-resolution mapping and cover all four chambers of the heart. The device was difficult to reprocess in the past because it contains microlumen technology, but Innovative Health has created new protocols and standards to remove blood and Heparin from the microlumen.","partners":"Biosense Webster, St. Jude Medical, Medtronic","customers":"Hospitals","investors":"NA","confidence":9,"key_topics":["FDA clearance","Catheter reprocessing","Cost reduction","Atrial fibrillation procedures","Microlumen technology"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":["Customers","Partners"],"acquisition_amount":"NA","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"M1ffa4kDslvbCrMhXV4jooFtC753nwWqKkTVkCLam02rrJDtWGEo6H","news_summary":"Innovative Health lands another catheter reprocessing clearance - Medical Design and Outsourcing","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"df5d84ac-21f9-4054-bfb4-f26fa1a282b2","date":"May 16, 2019","link":"https://www.fiercebiotech.com/medtech/j-j-s-biosense-webster-launches-cloud-based-cardiac-ablation-data-network","source":"www.fiercebiotech.com","visible":1,"analysis":{"tags":"Legal","company":"Questex LLC","layoffs":"N/A","summary":"The article discusses the terms of use and privacy policy of Questex LLC.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":8,"key_topics":["Questex LLC","Terms of use","Privacy Policy"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"N/A","investment_amount":"N/A","structured_issues":[],"acquisition_amount":"N/A","entityGrowthIconPath":"none;"},"sentiment":"N/A","analysisId":"ePOIDaL6Ue9gt45inNDqCOhSw6rgmHAWAL80sddC0myuDNtRxcRWjb","news_summary":"J&J's Biosense Webster launches cloud-based cardiac ablation data network","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"9018ded7-9f07-4cb8-b583-353d2a96e498","date":"Nov 19, 2018","link":"https://www.businesswire.com/news/home/20181118005008/en/Biosense-Webster-Launches-Report---Burden-Atrial","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"DC77cFH84nNAHCTOSpTglfpoRen0vXkuxWcAyNns6yDefJjQ6oQ0op","news_summary":"Biosense Webster Launches Report - The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic Across Europe","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"4e28965e-9a9d-4cfa-9b30-1e20e5eb04ac","date":"Oct 1, 2018","link":"https://cardiacrhythmnews.com/novel-tag-index-guided-software/","source":"cardiacrhythmnews.com","visible":1,"analysis":{"tags":"medical technology","company":"Johnson & Johnson","layoffs":null,"summary":"Johnson & Johnsons subsidiary, Biosense Webster, has received FDA approval for its VISITAG SURPOINT External Processing Unit. The approval allows for the enrollment of patients in a post-market approval study. The VISITAG SURPOINT Module is designed to simplify and standardize the workflow for ablating patients with paroxysmal atrial fibrillation (PAF). Over 30,000 patients have already been treated with the technology outside the US. The commercialization of the module in the US marks a significant milestone for Biosense Webster.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["FDA approval","VISITAG SURPOINT Module","catheter ablation","atrial fibrillation","commercialization"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"vza8Ue02XSQhPHTdE3SmDfsQz2D0Wsrfi5fnddYH4Zl90Sy0ZR6Cbw","news_summary":"Biosense Webster announces first patients enrolled in post-market approval study for its novel tag-index guided software","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b57d271d-6d93-40bd-9528-a76919a96d3c","date":"Jun 25, 2018","link":"https://globenewswire.com/news-release/2018/06/25/1528958/0/en/Stereotaxis-and-Johnson-Johnson-s-Biosense-Webster-Extend-Development-Alliance-and-Supply-Agreement.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"amendment, collaboration","company":"Stereotaxis, Inc.","layoffs":null,"summary":"Stereotaxis, Inc. has entered into an amendment to the long-term Development Alliance and Supply Agreement with Johnson & Johnson’s Biosense Webster, Inc. The amendment ensures the continued global availability of Biosense Webster’s family of commercially-available magnetic ablation catheters, and extends the existing arrangement under which Stereotaxis receives a royalty on the sale of those catheters, through December 31, 2022. The agreement does not modify the current non-exclusive nature of the collaboration.","partners":"Johnson & Johnson’s Biosense Webster, Inc.","customers":null,"investors":null,"confidence":8,"key_topics":["Amendment","Collaboration","Robotic technologies","Cardiac arrhythmias","Magnetic ablation catheters"],"date_of_event":"June 25, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bxz4w07q1B3Ngj5zxcFDLkiF7ZSiYbS3SnaHpJ9epBX5pY6sGz8KZh","news_summary":"Stereotaxis and Johnson & Johnson's Biosense Webster Extend Development Alliance and Supply Agreement","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0a69674a-0186-40ec-bc61-2a38ea724be1","date":"May 7, 2018","link":"https://www.prnewswire.com/news-releases/biosense-webster-inc-launches-sheath-designed-to-reduce-radiation-exposure-and-improve-ablation-procedure-efficiency-300643938.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical devices","company":"Biosense Webster, Inc.","layoffs":null,"summary":"Biosense Webster, Inc. has announced the availability of its CARTO VIZIGO Bi-directional Guiding Sheath in the United States. This sheath is the first of its kind that can be visualized on the CARTO 3 System during a catheter ablation procedure, reducing the need for fluoroscopy. The sheaths visualization on the system map eliminates the reliance on fluoroscopy to determine its location. This technology aims to improve the care delivered to patients by reducing radiation exposure for both medical staff and patients. The sheath was recently used at Massachusetts General Hospital. Biosense Webster, Inc. is a global leader in diagnosing and treating heart rhythm disorders and is part of the Johnson & Johnson Medical Devices Companies.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["CARTO VIZIGO","fluoroscopy","catheter ablation","radiation exposure","sheath visualization"],"date_of_event":"May 7, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"P9q5E3NohtuqIEHxbMQbiwmbrRoN6GVx8YgvJOhoQ2twjCFmDw0PD0","news_summary":"Biosense Webster, Inc. Launches Sheath Designed To Reduce Radiation Exposure And Improve Ablation Procedure Efficiency","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ade4d8b7-cbf9-473b-9718-6a1bfbd90aac","date":"Jan 1, 2013","link":"http://www.globes.co.il/en/article-1000810965","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Acquisition, Expansion","company":"Johnson & Johnson Biosense, Philips Healthcare, Edwards Lifescience, Life Technologies, Merck Serono","layoffs":"Not mentioned","summary":"The article discusses the impact of acquisitions and expansions of multinational healthcare companies in Israel. It highlights the success stories of Johnson & Johnson Biosense, Philips Healthcare, Edwards Lifescience, Life Technologies, and Merck Serono. These companies have established R&D centers in Israel, contributing to the growth of the local healthcare sector. The companies have also invested in Israeli start-ups, further boosting the countrys healthcare industry.","partners":"Not mentioned","customers":"Not mentioned","investors":"Lewis Pell, Medica Venture Partner, Oxford Bioscience Partners","confidence":"8","key_topics":"Acquisition, Expansion, R&D, Healthcare, Innovation","date_of_event":"January 1, 2013","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Acquisition, Expand","acquisition_amount":"Biosense was sold for $427 million, PVT was acquired for $155 million in cash","structuredIssuesShow":"#Acquisition, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nW4Z9wDzWrmvKbaxFPKIQGxi4FCgzR17g7AGzlhZTUIJmSyjIMimjc","news_summary":"Israel attracts global healthcare giants","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e0c9bdfc-5b5e-461d-9bbe-2e9bc4a66769","date":"Sep 29, 1997","link":"http://www.globes.co.il/en/article-362924","source":"www.globes.co.il","visible":1,"analysis":{"tags":"acquisition","company":"Biosense","layoffs":null,"summary":"Johnson & Johnson is set to acquire Biosense, a company that develops and manufactures products in the field of cardiology. The acquisition is estimated to be worth $400 million in Johnson & Johnson shares. Biosense will become part of Cordis, a subsidiary of Johnson & Johnson. Biosenses technology allows for accurate mapping and diagnosis of internal organs. Despite being a relatively new company with limited revenue, Johnson & Johnson forecasts that the market for Biosenses products will reach $2 billion.","partners":null,"customers":null,"investors":"Johnson & Johnson","confidence":8,"key_topics":["investment","acquisition","cardiology","technology","market"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":"$400 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uD4y5RNya14hU0jA2rpPnj4XbYzl2yPArdRj0xO7GagZ8mpqd7NeHq","news_summary":"Johnson & Johnson Buys Biosense For $400 Mln in Shares","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":10,"techcommunityinvolvement":null,"mediagallery":[{"id":"54e2b9bb-6ee2-4a5f-a486-7cdb113722e2","timestamp":"2020-04-30 13:59:35.000000","resources_type":1,"resources_title":"Ablation Catheter","resources_file_name":"$lSSPF0gevaUD9olWHiff8ySaAI9O35g33uL6hV8RFUAkBVvV8la8Y1","alt":"Ablation Catheter logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$lSSPF0gevaUD9olWHiff8ySaAI9O35g33uL6hV8RFUAkBVvV8la8Y1","url":"https://storage.googleapis.com/clean-finder-353810/$lSSPF0gevaUD9olWHiff8ySaAI9O35g33uL6hV8RFUAkBVvV8la8Y1"},{"id":"e1bd054b-c0d1-4c3f-baba-7c9916a6c843","timestamp":"2019-07-07 04:58:10.000000","resources_type":2,"resources_title":"","resources_file_name":"gl8Lyka9jEQ","alt":"","imageurl":"https://img.youtube.com/vi/gl8Lyka9jEQ/0.jpg","url":"http://youtu.be/gl8Lyka9jEQ"},{"id":"bc8c5550-2ab9-4cec-805f-b9a5890f72fd","timestamp":"2015-02-12 10:35:02.000000","resources_type":2,"resources_title":"","resources_file_name":"t4PEl5s9SAI","alt":"","imageurl":"https://img.youtube.com/vi/t4PEl5s9SAI/0.jpg","url":"http://youtu.be/t4PEl5s9SAI"}],"tags":["bioconvergence","medical-devices","real-time","mapping","diagnostics","therapeutics","surgery","catheters","cardiology","3d-technology","imaging","cardiovascular","hospitals","doctors","heart-diseases","ultrasound","treatments"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Je-v5kIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C","B2B"],"productstage":"Released","products":["CARTO"],"geomarkets":["Italy","United Kingdom","Sweden","Switzerland","Belgium","Germany","United States","Mexico","Global","South Africa","Portugal","Ireland","France","Spain"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Acquired","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[{"name":"Avi Shalgi","email":"ashalgi@biosensewebster.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4N6jxJYJDA","bounced":true,"claimed":0,"founder":0,"urlname":"avi-shalgi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg3snCywgM","position":"Director Business Development","last_name":"Shalgi","claimtoken":"SGyj4XDGOJxu0lcUccMf5ZqDYHZ6pKEqc6ceMSmBybPKISwu1P76eZ","first_name":"Avi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/avi-shalgi-27456643/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-01 20:11:02.000000","initials":"AS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eti  Godelnik","email":"eti@biosensewebster.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJ2Ou8oLDA","bounced":true,"claimed":0,"founder":0,"urlname":"eti-godelnik","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgvc279ggM","position":"Director Finance, Compliance & Legal","last_name":"Godelnik","claimtoken":"mDb18RknzCDFkhJkE5609owyR2XG9IXGOI0Zmudbf8ubtg2Ga6Q9zt","first_name":"Eti ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eti-godelnik-5b2b182/","unsubscribed":false,"is_activeuser":1,"additionalemail":"egodelnik@biosensewebster.com","claimedemaildate":"2022-12-01 20:09:52.000000","initials":"EG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-05-27T00:00:00.000Z","crunchbaseid":"biosense-webster","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Paz Eliav","creator_email":"paze@cet.ac.il","createdate":"2015-02-12T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE3_vACgw","date":"Sep 1997","amount":"$427M","source":"Migrated","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Johnson & Johnson","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwISPx9ELDA","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/mnc_page/johnson-johnson","acquiredcompany_mna_logokey":"$ZGZLV7DUlFkgUtW3RRol27Vr6RIBnPlja5TeXVQC7G3Ey1ZR0rrMIS.jpeg","acquiredcompany_mna_urlname":"/mnc_page/johnson-johnson","acquiredcompany_mna_homepage":"http://www.jnj.com/","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$ZGZLV7DUlFkgUtW3RRol27Vr6RIBnPlja5TeXVQC7G3Ey1ZR0rrMIS.jpeg","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":427000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/1993","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Biosense Webster","logourl":"https://storage.googleapis.com/clean-finder-353810/$eqVfeKBye9VzuBBd6GSDnEvVKaHzrvjKjKYtX8XdYGeYlWaGSXY1O8","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$eqVfeKBye9VzuBBd6GSDnEvVKaHzrvjKjKYtX8XdYGeYlWaGSXY1O8","seoabout":"Biosense Webster develops solutions designed to diagnose and treat cardiac arrhythmias. The company enables physicians to find and treat more types of dise...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Diagnostics Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"},{"depth":2,"name":"Ultrasound","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Je-v5kIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["TechnologyClassificationModel>Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA>Ultrasound#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Je-v5kIDA","TechnologyClassificationModel>Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Diagnostics Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA|2:>TechnologyClassificationModel>Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA/Ultrasound#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Je-v5kIDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Diagnostics Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Diagnostics Devices","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Diagnostics Devices"},{"title":"Medical Treatment & Therapeutics","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Simulation & Imaging","key":"0-0","path":"TechnologyClassificationModel>Simulation & Imaging","children":[{"title":"Ultrasound","key":"0-0-0","path":"TechnologyClassificationModel>Simulation & Imaging>Ultrasound"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Diagnostics Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"},{"depth":2,"name":"Ultrasound","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Je-v5kIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Diagnostics Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Simulation & Imaging","Ultrasound"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE3_vACgw","date":"Sep 1997","amount":"$427M","source":"Migrated","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Johnson & Johnson","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwISPx9ELDA","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/mnc_page/johnson-johnson","acquiredcompany_mna_logokey":"$ZGZLV7DUlFkgUtW3RRol27Vr6RIBnPlja5TeXVQC7G3Ey1ZR0rrMIS.jpeg","acquiredcompany_mna_urlname":"/mnc_page/johnson-johnson","acquiredcompany_mna_homepage":"http://www.jnj.com/","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$ZGZLV7DUlFkgUtW3RRol27Vr6RIBnPlja5TeXVQC7G3Ey1ZR0rrMIS.jpeg","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":427000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}